Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort studyMirela Diana Ilie, Gérald Raverot, Mathilde Cancel et al.|European Journal of Endocrinology|2022Cited by 52
BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort studyDario De Alcubierre, Emmanuel Jouanneau, Grigorios Gkasdaris et al.|European Journal of Endocrinology|2024Cited by 23
B-RAF and MEK inhibitor argeted therapy in papillary craniopharyngiomas: results from the French national multicenter studyAlcubierre Dario De, Emmanuel Jouanneau, Grigorios Gkasdaris et al.|Endocrine Abstracts|2024Cited by 0